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measures, sclerosing injections or portal shunting 
may become necessary in many survivors. 
Ascites. A combin'ation or' hypoalbuminemia, 
hyperaldosteronism, and renal failure associated 
with impairment of liver function may result in 
retention of sodium and total body water, whereas 
portal hypertension appears to b~ mainly respon-
sible for the localization of excess f1uid in the 
abdomen. Sudden ascites can be precipitated dur-
ing the course of chronic liver disease by intercur-
rent infections, hemorrhage, or surgery. Acute 
ascites is often reversed by limiting daily dietary 
sodium to 500 mg. Children on this diet should 
receive an adequate caloric and protein intake. 
"Chronic" ascites, which is a reflection of pro-
gressive liver decompensation and portal hyper-
tension, gradually results in discomfort, dyspnea, 
and severe limitation of physical activity. In addi-
tion to dietary management, successful diuresis in 
these patients may be accomplished with the com-
binations of diuretic agents and inhibitors of so-
dium-potassium exchange. 
Treatment is initiated in the hospitaL A dietitian 
prescribes salt-depleted proteins and starches to 
augment caloric intake and to make the diet more 
palatable and adds vitamin supplements. In chil-
dren with advanced cirrhosis, protein intake is 
limited to 1 gm/kg/day because of the danger of 
hepatic coma. The most useful diuretic is spiron-
olactone, 3 mg/kg/day. Dosages may be decreased 
or increased according to the diuretic response. A 
mean 24-hour weight loss of up to 1 pound is 
considered satisfactory. Serum sodium and potas-
sium levels should be determined daily, especially 
during the initial stages of therapy. Spironolactone 
usually obviates the need for potassium supple-
ments. Chlorothiazide (30 mg/kg/day) in combi-
nations with spironolactone up to 7 mg/kg/day 
often controls refractorv ascites. Furosemide, 2 
mg/kg/dose, is reserved f~r the most resistant cases. 
Coma. Coma can be precipitated in a cirrhotic 
patient by infection, f1uid imbalance, diuretic ther-
apy, hemorrhage, and surgery. Appropriate re-
spective measures include antibiotics, correction of 
over- or underhvdration, removal of diuretics, 
prevention of heinorrhage and, obviously, avoid-
ance of surgery. Current therapy of hepatic coma 
is based on efforts to diminish ammonia by elim-
inating protein intake during the comatose period 
and using poorly absorbed antibiotics, such as 
neomycin, kanamycin, or paromomycin, to control 
intestinal ammonia-producing bacteria. A daily 
oral dose of neomycin, 2 to 4 gm, is given during 
the acute periods; smaller doses may be required 
for maintenance. Lactulose, 60 gm/day in 3 doses, 
is also effective in control of ammonia. This non-
absorbable sugar acts as substrate for acid produc-
tion by colonic flora, resulting in flux of ammonia 
from the circulation to the intestinal lumen. Other 
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measures include control of renal ammonia bv 
maintenance of normal potassium levels and avoid-
ance of diuretics. 
Patients \\'ith uncomplicated chronic liver disease 
usualh recover when treated in this manner, but 
those ~yDith progressive liver disease usually do not. 
Liver transplantation may offer a chance for sur-
vival in such patients. 
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MALIGNANT TUMORS 
Mass lesions of the liver diagnosed by radiologic 
studies should be considered malignant until 
proved otherwise. The most common malignant 
tumor in children is hepatoblastoma. Hepatocel-
lular carcinoma is the second most common and 
usually occurs in older children. Sarcomas of the 
liver, 'such as rhabdomyosarcoma and angiosar-
coma, are rare. None of these has a favorable 
outlook, but fibrolamellar hepatocellular carci-
noma, which is common in older children and 
young adults, has a better prognosis than other 
types of liver malignancy. 
The treatment for all malignant liver tumors is 
complete surgical excision by anatomic hepatic 
resection. Hepatic resections of more than the 
right or left lobe of the liver can be performed 
quite safely. For example, a large tumor occupying 
the right lobe and the medial segment of the left 
lobe can be resected by right hepatic trisegmen-
tectomy, leaving only the left lateral segment of 
the left lobe (to the left of the falciform ligament); 
or a large tumor occupying the left lobe and 
anterior segment of the right lobe can be resected 
by left hepatic trisegmentectomy, leaving only the 
posterior segment of the right lobe. These exten-
sive right and left hepatic trisegmentectomies can 
now be performed by experienced surgeons with 
less than a 5% operative mortality. 
We have found that computed tomography is 
most useful to assess the extent of the tumor, but 
it can be often misleading, particularly when a 
large tumor distorts normal anatomic boundaries. 
If resectability is uncertain after extensive pre-
operative investigations, the patient should be re-
ferred to a surgeon who is experienced in major 
hepatic resections rather than submitted to ex-
ploratory celiotomy by someone who is unpre-
pared to undertake a definitive procedure. 
After curative hepatic resections, we often rec-
ommend that patients receive adjuvant chemo-
therapy for at least a year. We have been using -
combination chemotherapy with doxorubicin, dac-
tinomycin, vincristine, cyclophosphamide, and 
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often mitomycin. The value of this approach has 
not been validated in randomized trials, but the 
patients who have received adjuvant chemother-
apy have seemed to live longer, tumor-free. 
Liver transplantation is an ineffective cancer 
therapy at this time. We have treated 50 patients 
with various primary liver malignancies by ortho-
topic liver transplantation (total hepatectomy and 
liver replacement). Nearly all the patients who 
received liver replacement for the treatment of 
nonresectable large malignant tumors developed 
tumor recurrences, with the exception of those 
with fibrolamellar hepatomas. Fibrolamellar he-
patocellular carcinoma seemed to carry a better 
prognosis after liver replacement, just as after 
partial liver resection. On the other hand, most of 
the patients who have received liver replacement 
primarily for other end-stage liver diseases, such 
as tyrosinemia and alphal-antitrypsin deficiency 
disease, and whose malignant liver tumors were 
small and incidental, survived tumor-free for sev-
eral years. 
The most common metastatic liver tumors in 
children are neuroblastoma and Wilms' tumor. 
Although chemotherapy and radiation therapy 
may be helpful in treating these metastatic tumors, 
the lesion should be excised whenever possible, 
particularly if it is localized to part of the liver. 
We have performed nearly 100 liver resections for 
metastatic liver tumors without any operative mor-
tality. 
BENIGN TUMORS 
Most of the benign tumors of the liver are 
asymptomatic and are found incidentally during 
studies for other disorders or during abdominal 
operations. 
Hemangiomas are the most common benign 
tumors of the liver. Giant cavernous hemangiomas 
should be treated by surgical excision, particularly 
if they are symptomatic. The majority of giant 
cavernous hemangiomas require lobectomies or 
trisegmentectomies of the liver, but some, which 
are located on the surface of the liver or which 
are pedunculated, can be enucleated along pseu-
docapsular margins without significant loss of nor-
mal liver tissue. 
Infantile hemangioendotheliomas are most 
often seen in infants during the first 6 months of 
life and are distinct from cavernous hemangiomas. 
The lesions should be excised by anatomic hepatic 
resection whenever possible. If the patient's con-
dition prohibits surgery, treatment with predni-
sone, diuretics, and digoxin can be used initiallv. 
Response to prednisone may allow surgery to be 
performed safely in 2 weeks. In extensive lesions, 
radiation to the liver may be used after pathologic 
diagnosis is confirmed by open liver biopsy. Fa-
vorable responses to steroids, radiation, and he-
patic artery ligation or embolization have been 
reported. The treatment should be vigorous, be-
cause complete regression and cure are possible. 
. Other benign tumors include adenoma, hamar-
toma, focal nodular hyperplasia, fibroma, and 
teratoma. Radiologic differentiation of these be-
nign tumors from malignant tumors is unreliable. 
Pathologic confirmation of benign tumor is man-
datory for each lesion. Large benign tumors should 
be treated by surgical excision, particularly if they 
are symptomatic. Adenoma has a tendency to 
rupture and cause life-threatening hemorrhage. 
Some adenomas cannot be easily differentiated 
from low-grade hepatocellular' carcinoma by 
needle biopsies. If the diagnosis is uncertain, the 
lesion should be excised with an adequate margin 
without delay. 
Portal Hypertension 
SHEILA SHERLOCK, D.B.E., M.D. 
Portal hypertension is nearly always due to ob-
struction to blood flow in the portal venous system. 
It can be divided into two main categories: pre-
sinusoidal, and sinusoidal or postsinusoidal. It is 
important to make the distinction. In the pre-
sinusoidal type of portal hypertension, hepatocel-
lular function is intact, whereas in the second form 
it is defective, and liver cell failure is liable to be 
precipitated by hemorrhage. Treatment depends 
upon accurate localization of the site of obstruction 
and, if possible, knowledge of the cause. 
Management Before and Between Hemor-
rhages. Apart from any treatment necessary for 
underlying cirrhosis, the child should be allowed 
to lead as normal a life as possible and attend 
ordinary school. Provided the spleen is not too 
large, games and physical education may be al-
lowed. Particularly vigorous sports, such as foot-
ball, must be forbidden. The child should not be 
allowed to become overly tired. The school prin· 
cipal should be informed of the situation, and the 
parents should not press the child to be too com-
petitive in either work or play. 
Note should be taken of fecal color and the 
parents told to report if it becomes black. Hemo-
globin estimations should be done if the child 
appears anemic or passes black stools. Oral iron 
treatment is given as required. The cirrhotic child 
requires occasional estimations of the prothrombin 
time. and intramuscular vitamin KJ (5 mg) may 
be useful from time to time. 
Hemorrhage commonly follows an upper res-
piratory tract infection, and this should be avoided 
if possible and all necessary inoculations given. If 
infection develops, it should be taken seriously 
and broad-spectrum antibiotics given from the 
